MINIjectTM, iSTAR Medical’s minimally invasive glaucoma surgery (MIGS) device, will be presented as part of the “On the Cutting Edge” talks during the opening session at the prestigious, invitation-only Interventional Glaucoma Congress (IGC) meeting in Chicago from 7 to 11 October 2021. Dr Brian Flowers, who will present iSTAR Medical’s technology, specializes in glaucoma and cataracts at Ophthalmology Associates, in Fort Worth, Texas, and is one of the implanting surgeons in MINIject trials.
Dr Flowers will speak to the top 100 glaucoma surgeons in North America about how MINIjectTM differs from other MIGS due to its proprietary STAR® material, and will present the latest clinical data from MINIjectTM trials.
On 15 July 2021, iSTAR Medical announced FDA approval for a pivotal trial for MINIjectTM in glaucoma patients in the United States. The IGC meeting is an invitation-only, think tank–style meeting for glaucoma specialists to exchange ideas on innovations and advanced practices for improved patient care. It is chaired by glaucoma specialists Doctors Ike Ahmed, Richard Lewis and Arsham Sheybani.
